Vacunación anti-COVID-19: La realidad tras los ensayos clínicos

After the start of vaccination against SARS-CoV-2, enough clinical experience is already accumulating, in the real world and outside clinical trials, to resolve some of the questions that are still pending about this problem. The Scientific Committee on COVID-19 of the Madrid College of Physicians h...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz-Galiana, Julián, Cantón, Rafael, Ramos, Pilar De Lucas, García-Botella, Alejandra, García-Lledó, Alberto, Gómez-Pavón, Javier, del Castillo, Juan González, HernándezSampelayo, Teresa, Martín-Delgado, Mari Cruz, Sánchez, Francisco Javier Martín, Martínez-Sellés, Manuel, García, José María Molero, Guillén, Santiago Moreno, RodríguezArtalejo, Fernando, Bouza, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Quimioterapia 2021
Materias:
Revisión
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638833/
https://www.ncbi.nlm.nih.gov/pubmed/33906339
http://dx.doi.org/10.37201/req/035.2021
Descripción
Sumario:After the start of vaccination against SARS-CoV-2, enough clinical experience is already accumulating, in the real world and outside clinical trials, to resolve some of the questions that are still pending about this problem. The Scientific Committee on COVID-19 of the Madrid College of Physicians has discussed and reviewed some of these issues with a multidisciplinary approach. The following document is an attempt to answer some of these questions with the information available so far. This document is structured in questions on different aspects of the indications, efficacy and tolerance of anti-COVID-19 vaccination.

Ejemplares similares